Clinical trial

Aspirin in Young Psychotic Patients

NCT02685748

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-07-20

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2017-07-20Date precision: day

Registry last updated2024-09-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychosisunresolved

Acute Psychosisunresolved

Schizophreniaunresolved

Interventions

AspirinDRUG · verified · RxNorm: aspirin

PlaceboDRUG

PantoprazoleDRUG · verified · RxNorm: pantoprazole

Sponsors & collaborators

Clinic for Psychiatric Disorders, Dr Laza Lazareviclead sponsor

Stanley Medical Research Institutecollaborator

Mapped research locations

BelgradeSerbia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02685748 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.